Rosuvastatin Calcium Tablets

DRUG6 trials

Sponsors

GlaxoSmithKline, Jiangsu HengRui Medicine Co., Ltd., Beijing Inno Medicine Co., Ltd., Beijing Dongfang Biotech Co., Ltd., Shandong Suncadia Medicine Co., Ltd.

Conditions

Atherosclerotic Cardiovascular DiseaseChronic Hepatitis BDiabetes Mellitus, Type 2HypercholesterolaemiaHyperlipidemiaObesityOverweight

Phase 1

Rosuvastatin Calcium Bioequivalence Study - Fast

CompletedNCT01711749

GlaxoSmithKlineHypercholesterolaemia

Start: 2013-02-25End: 2013-03-13Updated: 2017-06-20

A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

CompletedNCT05273775

Jiangsu HengRui Medicine Co., Ltd.Chronic Hepatitis B

Start: 2022-04-29End: 2022-06-23Updated: 2022-12-23

YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

CompletedNCT06048588

Beijing Inno Medicine Co., Ltd.Atherosclerotic Cardiovascular Disease

Start: 2023-10-08End: 2025-04-27Updated: 2025-04-30

Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects

CompletedNCT06247748

Beijing Dongfang Biotech Co., Ltd.Diabetes Mellitus, Type 2, Overweight

Start: 2023-10-19End: 2024-04-15Updated: 2024-08-21

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

CompletedNCT07097831

Shandong Suncadia Medicine Co., Ltd.Hyperlipidemia

Start: 2025-10-09End: 2025-11-07Updated: 2026-01-09

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

RecruitingNCT07269756

Shandong Suncadia Medicine Co., Ltd.Obesity, Overweight

Start: 2025-12-08End: 2026-02-28Target: 40Updated: 2025-12-31